On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in Obninsk, in a patient diagnosed with metastatic breast cancer. Radiation Oncologist Dr. Razvan Galalae from Essen, Germany, performed the treatment with the support of Prof. Yona Keisari, Chief Scientific Officer of Alpha Tau and a co-inventor of Alpha DaRT. This patient is the first in a clinical trial of Alpha DaRT just initiated in Obninsk. B

In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the emergency room for uncontrolled vomiting. Their whole world seemed to shatter when the doctors realized that the problem was caused by a large tumor in the lower part of his brain. A complex procedure known as transnasal endoscopic skull base surgery, essentially aiming to remove the tumor through the nose, had successfully treated similar cases

As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation therapy, Alpha DaRT, has the potential to create a paradigm shift in cancer care. Despite advances in conventional therapies, there are still many patients who succumb to their disease or who are unable to tolerate existing treatments. I am proud to be part of an Israeli startup company that is working to expand cancer care for millions of patient